gentaur logogentaur logo
x

SARS-CoV-2 (COVID-19) Omicron Variant Spike RBD (His-Avi Tag) Recombinant Protein

SARS-CoV-2 (COVID-19) Omicron Variant Spike RBD (His-Avi Tag) Recombinant Protein
SARS-CoV-2 (COVID-19) Omicron Variant Spike RBD (His-Avi Tag) Recombinant Protein

SARS-CoV-2 (COVID-19) Omicron Variant Spike RBD (His-Avi Tag) Recombinant Protein

710.05 €

710.05 €
In Stock
quantity
product details

Catalog number: 223 - 95-128

Product Category: Business & Industrial > Science & Laboratory

Supplier:

ProSciGentaur

Size: 0.05 mg

Related Products

SARS-CoV-2 (COVID-19) Omicron Variant Spike S1 (His-Avi Tag) Recombinant Protein

95-129

SARS-CoV-2 (COVID-19) Omicron Variant Spike S1 (His-Avi Tag) Recombinant Protein

SARS-CoV-2 Omicron variant, a variant of concern (VOC), known as B.1.1.529, was detected in South Africa at the end of November in 2021. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 90% of the new cases. Omicron variant spike protein carries around 30 amino acid changes, including mutations, deletions and insertions, in which the receptor binding domain (RBD) protein contains 15 mutations. Enhanced transmission of the Omicron variant was observed globally, which is at least 70 times more contagious than the other variants. The Omicron variant affects the effectiveness of COVID-19 vaccine and is resistant to neutralization (monoclonal antibody treatments) to a large extent.

710.05 €

SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein C-terminal His Tag Lyophilized

ICOV2SRBDRCTHISLY100UG

SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein C-terminal His Tag Lyophilized

SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein C-terminal His Tag Lyophilized

1333.00 €

SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein C-terminal His Tag

ICOV2STRBDSD1RCHIS100UG

SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein C-terminal His Tag

SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein C-terminal His Tag

1417.00 €

SARS-CoV-2 Omicron variant, a variant of concern (VOC), known as B.1.1.529, was detected in South Africa at the end of November in 2021. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 90% of the new cases. Omicron variant spike protein carries around 30 amino acid changes, including mutations, deletions and insertions, in which the receptor binding domain (RBD) protein contains 15 mutations. Enhanced transmission of the Omicron variant was observed globally, which is at least 70 times more contagious than the other variants. The Omicron variant affects the effectiveness of COVID-19 vaccine and is resistant to neutralization (monoclonal antibody treatments) to a large extent.